LISA SANDRIK: Open Payments
NPI 1255981668 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 21 payments from 11 companies in 2025. Trend: 2023 $1,203 · 2024 $751 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| Amgen Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: LEQVIO, NEXLETOL, Repatha, WAINUA, JARDIANCE, LifeVest, Kerendia, FUROSCIX.
Industry payments across CA — which companies pay providers there.
